Skip to content

Clinical trials

Phase 3 Anxiety Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 3 Country / region: Canada Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20053
20064
20081
20091
20101
20111
20131
20161
20181
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status3
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Cephalon2
McMaster University2
Sanofi2
Canadian Breast Cancer Research Alliance1
Corporation de Recherche en Neuropsycho Pharmacologie de Quebec1
Dr. Roumen Milev1
Eli Lilly and Company1
Lady Davis Institute1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders19
Generalized Anxiety Disorder5
Pain3
Agoraphobia2
Marijuana Abuse2
Panic Disorder2
Phobia, Social2
Breast Neoplasms1
Hot Flashes1
Influenza, Human1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.